This is a snippet of the transcript, sign up to read more.
Optimally, the operating arm gets involved at the tail end of commercial diligence and the beginning of operational diligence. The way I think about this, and we did this when I was at Vista, is it's almost like a stage gate process. The easiest way to describe it, and I borrowed this from someone else, is deal killers, model movers, and value creation planning.
This is a snippet of the transcript, sign up to read more.
In the deal killer space, it should really be the deal team asking if the market is big enough and if we can make the investment thesis work. You might involve the operating team, like in a software business, where the product and tech team ensures there's not an overwhelming amount of tech debt. You may also check for any significant legal issues or regulatory changes that could potentially impact the business.
This is a snippet of the transcript, sign up to read more.
You have the deal killers, and the operating team is very surgically involved, if at all, in that portion. You reach IC1, and then in the model movers, the operating team becomes much more involved. You're assessing the models, determining the levers to use, and deciding how much to invest in sales and what to expect in return. You consider ratios and how they look.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research